Invention Grant
- Patent Title: Endolysin polypeptide
-
Application No.: US17092382Application Date: 2020-11-09
-
Publication No.: US11339386B2Publication Date: 2022-05-24
- Inventor: Martin Johannes Loessner , Fritz Eichenseher
- Applicant: Micreos Human Health B.V.
- Applicant Address: NL The Hague
- Assignee: Micreos Human Health B.V.
- Current Assignee: Micreos Human Health B.V.
- Current Assignee Address: NL The Hague
- Agency: N.V. Nederlandsch Octrooibureau
- Priority: EP15185337 20150915
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N9/36 ; C07K14/31 ; A01N43/50 ; A61K38/47 ; A61K38/00
Abstract:
The invention relates to the field of medicine, specifically to the field of treatment of conditions associated with Staphylococcus infection. The invention relates to a novel endolysin polypeptide specifically targeting a bacterial Staphylococcus cell. The invention further relates to said endolysin polypeptide for medical use, preferably for treating an individual suffering from a condition associated with Staphylococcus infection.
Public/Granted literature
- US20210130802A1 Novel endolysin polypeptide Public/Granted day:2021-05-06
Information query
